ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ASXSF Elysee Development Corp (PK)

0.23362
0.00 (0.00%)
Last Updated: 16:59:49
Delayed by 15 minutes
Share Name Share Symbol Market Type
Elysee Development Corp (PK) USOTC:ASXSF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.23362 0.2069 0.2605 0.00 16:59:49

Remedent, Inc. to Demonstrate ``Metatray'' Tooth Whitening System at Chicago Dental Society's Midwinter Meeting; Conference at L

22/02/2006 1:30pm

Business Wire


Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Elysee Development (PK) Charts.
Remedent, Inc. (OTC BB: REMI), a leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products, today announced that it will demonstrate its Metatray(TM) tooth whitening system at the Midwinter Meeting of the Chicago Dental Society. The meeting begins February 24 at Chicago's Lakeside Center at McCormick Place and runs through February 26. The demonstrations will take place at Remedent's booth (#2561) throughout the course of the convention. In addition, representatives of HANSAmed Limited, of Ontario, Canada, will be at Remedent's booth during the convention. HANSAmed has recently signed a distribution agreement with Remedent to make the Metatray tooth whitening system available in Canada. Remedent sees this as a significant step toward a substantial market presence in North America. Remedent is also pursuing similar agreements with companies in the United States. The Metatray(TM) combined with the Meta foam strips form a revolutionary new whitening solution that brings an extra dimension to teeth whitening. It is also the world's first 'at home' power bleaching system. It produces high quality, long-lasting results similar to in-office procedures. The Metatray concept is the first whitening system that combines the traditional mouth tray with the latest technology in light and heat energy. These are critical elements to enhance the whitening process of the Meta foam strips and dramatically shorten the treatment time. Reality Publishing Company, which serves the dental community with product reports and whose flagship publication Reality is considered the "bible of cosmetic dentistry," has nominated Remedent's Metatray for an award in the category of "Most Unique First Look." Remedent, Inc., a publicly listed company trading on the OTCBB, strives to be a world leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products. Remedent products are renowned for their technological superiority and ease-of-use. Based in Deurle, Belgium, Remedent has successfully researched, developed and manufactured all of its own products. These products are now distributed in more then 35 countries worldwide. Remedent consists of two divisions: one that serves the dental community and one that is focused on the over-the-counter consumer market. Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.

1 Year Elysee Development (PK) Chart

1 Year Elysee Development (PK) Chart

1 Month Elysee Development (PK) Chart

1 Month Elysee Development (PK) Chart

Your Recent History

Delayed Upgrade Clock